UNSPSC 51373418: Caffeine/codeine/menthol/pheniramine/phenylephrine/sodium/sodium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373418 Caffeine/codeine/menthol/pheniramine/phenylephrine/sodium/sodium is a Commodity code under which state and local governments procure pharmaceutical products and injectable solutions for healthcare and public health programs. Recent solicitations show purchasing activity centered on parenteral products—intravenous and nutrition solutions, including controlled substances—and opioid-response medications such as naloxone. The Washington State Department of Corrections issued an RFQ in September 2026 for parenteral nutrition solutions (TPN and PPN), intravenous products, and other injectable pharmaceuticals to supply eight correctional facilities across three regions, with 24-hour delivery requirements and multiple contractor awards anticipated per region. Issuing bodies for this code include state corrections departments and county public health authorities; both solicitations named above represent institutional healthcare procurement rather than retail pharmacy supply. Set-asides and diversity goals appear in state corrections purchasing, with Washington DOC explicitly targeting small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation.

Recent activity spans Washington State and Florida. The Washington State Department of Corrections RFQ (RFQQK13020) has a response deadline of October 7, 2026, with a pre-bid conference on September 23, 2026 and questions due September 22, 2026; the contract runs from November 26, 2026 through June 30, 2030 with discretionary extension rights, firm pricing for the initial two-year term, and multiple awards up to three bidders per region. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to a county health building; the bid deadline was July 26, 2023 (note: this opportunity appears aged relative to its posting date and may reflect data lag). Both solicitations require vendor compliance with drug-free workplace certification, E-Verify, and specified insurance requirements including general and professional liability coverage.